I presented HB 1366 this week to the Committee on Emerging Issues.  This bill will allow a pathway for the substitution of Biosimilar Medications for Biologic medications.

These medications are very expensive medications and most commonly found in oncology, arthritis and other types of disease processes.  If this bill passes and makes it across the Governor’s desk it will result in a significant savings for patients as well as for the state of Missouri.

I was very pleased with the hearing this week, there was no opposition voiced to the bill and many groups voiced supported the bill.  This bill will be voted in committee next week and if it passes this committee will go to the second level of committee for review.  If the bill passes the second committee level it will be heard on the House Floor.